Lucus Advisors LLC decreased its stake in Aetna Inc. (NYSE:AET) by 38.2% during the second quarter, Holdings Channel reports. The firm owned 2,829 shares of the company’s stock after selling 1,752 shares during the period. Lucus Advisors LLC’s holdings in Aetna were worth $346,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in the company. Renaissance Technologies LLC boosted its stake in Aetna by 111.5% in the first quarter. Renaissance Technologies LLC now owns 412,190 shares of the company’s stock valued at $46,310,000 after buying an additional 217,300 shares during the period. PGGM Investments boosted its stake in Aetna by 54.7% in the second quarter. PGGM Investments now owns 794,893 shares of the company’s stock valued at $97,080,000 after buying an additional 280,978 shares during the period. Bridger Management LLC purchased a new stake in Aetna during the first quarter valued at $62,926,000. Panagora Asset Management Inc. boosted its stake in Aetna by 10.2% in the first quarter. Panagora Asset Management Inc. now owns 1,212,479 shares of the company’s stock valued at $136,222,000 after buying an additional 112,572 shares during the period. Finally, Samlyn Capital LLC boosted its stake in Aetna by 12.9% in the first quarter. Samlyn Capital LLC now owns 950,363 shares of the company’s stock valued at $106,773,000 after buying an additional 108,650 shares during the period. Institutional investors own 91.95% of the company’s stock.
Shares of Aetna Inc. (NYSE:AET) traded up 0.37% on Friday, reaching $115.45. The company’s stock had a trading volume of 1,839,122 shares. Aetna Inc. has a 52-week low of $92.42 and a 52-week high of $123.57. The company has a market cap of $40.50 billion, a price-to-earnings ratio of 16.92 and a beta of 0.62. The stock has a 50-day moving average of $116.86 and a 200 day moving average of $115.71.
Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $2.21 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.12 by $0.09. Aetna had a return on equity of 16.44% and a net margin of 3.89%. The firm had revenue of $15.95 billion for the quarter, compared to analyst estimates of $15.69 billion. During the same period last year, the company earned $2.05 EPS. The business’s quarterly revenue was up 4.7% compared to the same quarter last year. On average, equities research analysts forecast that Aetna Inc. will post $8.05 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 0.87%. Aetna’s dividend payout ratio is presently 14.73%.
Several analysts have recently weighed in on AET shares. Credit Suisse Group AG restated a “hold” rating and set a $120.00 price target on shares of Aetna in a report on Tuesday, August 30th. Leerink Swann reiterated an “outperform” rating on shares of Aetna in a report on Wednesday, August 24th. Evercore ISI initiated coverage on Aetna in a report on Thursday, September 22nd. They issued a “buy” rating and a $128.00 target price on the stock. Jefferies Group reiterated a “hold” rating on shares of Aetna in a report on Tuesday, August 23rd. Finally, Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $133.00 target price on the stock in a report on Tuesday, July 19th. Seven analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $132.79.
In related news, Director Jeffrey E. Garten sold 7,100 shares of Aetna stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total transaction of $827,221.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Shawn M. Guertin sold 45,328 shares of Aetna stock in a transaction that occurred on Tuesday, August 23rd. The shares were sold at an average price of $120.21, for a total value of $5,448,878.88. Following the sale, the insider now owns 44,883 shares in the company, valued at $5,395,385.43. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.